Tamoxifen contraindicated in women with hereditary angioedema?

Annals of Oncology

Volumn 20, Issue 7, 2009, Pages 1281-1282

  Rousset Jablonski, Christine ^a   Thalabard, J C ^a   Gompel, A ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; LETROZOLE; TAMOXIFEN;

AGED; ANAMNESIS; ANGIONEUROTIC EDEMA; BREAST CANCER; CANCER RECURRENCE; CASE REPORT; DRUG CONTRAINDICATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; MASTECTOMY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 67650394386     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp295     Document Type: Letter

References (5)

1. Agostoni A, Aygoren-Pursun E, Binkley KE et al. Hereditary and acquired angioedema: ProblPms and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 2004; 114: S51-S131.
2. Bork K. Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutations. Immunol Allergy Clin North Am 2006; 26: 709-724.
3. Bork K, Fischer B, Dewald G. Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. Am J Med 2003; 114: 294-298.
4. Gompel A. Genomic effects of estradiol in Angioedema. Implications for contraception and hormonal menopause treatment. Rev Fr Allergol Immunol Clin 2008; 48: 448-451.
5. Bowen T, Cicardi M, Farkas H et al. Canadian 2003 International Consensus Algorithm for the diagnosis, therapy, and management of hereditary angioedema. J Allergy Clin Immunol 2004; 114: 629-637.